27th Annual EuroMeeting

Back to Agendas

PRIMARY FACTORS FOR TRIAL LOCATION

Session Chair(s)

Dorthe Poulsen, LLM

Eu-coordinator and chief legal adviser

Danish Health and Medicines Authority, Denmark

Which factors are decisive for the decision to conduct a clinical trial in a certain part of the world? There is no doubt that the EU competes with other parts of the world such as the BRIC countries. In this session, we’ll have a look at the EU in a more global context. Case stories are welcomed as this would be illustrative for participants.

Speaker(s)

Country Allocation in Global Perspective

Henrik Troelsen

Novo Nordisk, Denmark

Director, Global Trial Allocation

The Swedish Way to Foster Innovation

Christer Backman, LLM

Medical Products Agency, Sweden

International Coordinator & Senior Expert

Japanese Policy & Japanese Trial Sites

Toshiyoshi Tominaga, PhD

Keio University Hospital, Japan

Project Professor

Have an account?